Exact Sciences Should Benefit from Pfizer’s News Today

Exact Sciences Should Benefit from Pfizer’s News Today

Source: 
Motley Fool
snippet: 

Pfizer announced an expedited FDA review for its drug to treat colorectal cancer, which Exact Sciences’ lead diagnostic test also targets.